Share on StockTwits

Analysts at Piper Jaffray boosted their price target on shares of LHC Group (NASDAQ:LHCG) from $25.00 to $28.00 in a research report issued to clients and investors on Monday. Piper Jaffray’s price objective indicates a potential upside of 16.04% from the stock’s previous close.

LHC Group (NASDAQ:LHCG) traded up 1.49% on Monday, hitting $24.49. The stock had a trading volume of 17,181 shares. LHC Group has a one year low of $19.69 and a one year high of $26.43. The stock has a 50-day moving average of $21.96 and a 200-day moving average of $21.94. The company has a market cap of $435.7 million and a P/E ratio of 20.45.

LHC Group (NASDAQ:LHCG) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $0.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.32 by $0.03. The company had revenue of $188.90 million for the quarter, compared to the consensus estimate of $179.90 million. During the same quarter in the previous year, the company posted $0.34 earnings per share. The company’s revenue for the quarter was up 13.6% on a year-over-year basis. Analysts expect that LHC Group will post $1.23 EPS for the current fiscal year.

Separately, analysts at Oppenheimer reiterated an “outperform” rating on shares of LHC Group in a research note on Friday. They now have a $27.00 price target on the stock, up previously from $26.00. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. LHC Group presently has an average rating of “Hold” and a consensus price target of $25.25.

LHC Group, Inc (NASDAQ:LHCG) provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals (LTACHs).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.